Categories: Latest

Vitafoods Asia showcases Purity of Provenance with Astaxanthin

The event that shapes the food industry for optimal health through science and innovation, returns to Singapore between 25-26 September 2019. 

Singapore, August 21, 2019: Provenance matters as consumers care how pure or pristine the environment in which algae, or other natural products that we consume, are grown. They educate themselves as to provenance. For example, Chinese consumers prefer products from Australia or New Zealand because they trust the provenance. 

Now, a Chilean company is hoping to carry their message of provenance across to Asian buyers of nutraceuticals at Vitafoods Asia 2019. The Atacama Desert in Chile is a unique and privileged place which has the optimal natural conditions to culture Haematococcus pluvialis, the only true source of natural Astaxanthin. 

Atacama Bio Natural Products, who produce top quality Astaxanthin products from Haematococcus pluvialis, will launch a new product, NatAxtinTM at Vitafoods Asia 2019. NatAxtinTM is microalgae that has been grown through biomimicry. 

It is technologically demanding to produce a quality Astaxanthin product at an industrial scale over time, because haematococcus pluvialis is a natural-occurring organism that thrives in ponds and in places that have no environmental contamination. Additionally, such algae only start producing Astaxanthin under particular stress conditions, mainly intense sunlight. 

To manufacture Astaxanthin, the culturing process has to imitate intense light conditions either through access to such conditions – taking advantage of Chile’s high solar radiation, pristine and clear skies, and pure underground water from the Andes – or by fabricating them using artificial light, or by encapsulating the algae in tubes. 

The origin of Astaxanthin matters. The more natural the production process, the less intervention required, yields a product that is closer to that which nature produces. 

Atacama Bio Natural Products use a raceway photobioreactors production system, which takes advantage of the geographical and climatological conditions in the Atacama Desert. The method is sustainable, consumes little energy (as it uses solar energy) and closely resembles the way that nature intended for Haematococcus pluvialis to grow. The entire production process also has less ecological impact. 

Algae create biomass by absorbing carbon dioxide directly from the atmosphere while delivering oxygen, thus contributing to a lesser carbon footprint. The facilities in which the algae are grown are fed by pure underground water that filters directly from the peaks of the Andes Mountain Range. This production process creates an essentially natural Astaxanthin product. 

Because Atacama Bio Natural Products take advantage of their topological conditions, it lowers the cost of production, a benefit that is transferred to consumers. 

To learn more, visit Atacama Bio Natural Products at Stand D34 at the Vitafoods Asia 2019 exhibition (vitafoodsasia.com) between 25-26 September 2019 in Singapore.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Bayer Introduces Bepanthen in India as New Survey Reveals Dry Skin Affects 1 in 2 Indians

·        World's no.1 skincare brand Bepanthen* launches in India, as a solution to tackle India's widespread dry skin…

5 hours ago

Lung Cancer in India: Understanding Risk Factors and the Importance of Early Detection

By Dr. Pavan Yadav, Lead Consultant - Interventional Pulmonology & Lung Transplantation, Aster RV Hospital.…

23 hours ago

10 Winter Skin Care Tips Dermatologists Swear By

Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru  Winter weather brings a host…

4 days ago

Fighting Viral Hepatitis in India: Prevention, Risks, and the Path to Better Health

By Dr. Naveen Ganjoo, Senior Consultant - Hepatology & Integrated Liver Care, Aster RV Hospital…

4 days ago

Hon’ble Prime Minister Shri Narendra Modi Inaugurates LyfiusPharma’s Flagship Penicillin-G Facility at Kakinada, Andhra Pradesh

Under the Production Linked Incentive(PLI)scheme, Lyfius Pharma Private Limited(LyfiusPharma) invested ₹2,500 crores in Penicillin-G( Pen-G)facility…

5 days ago